Dr. Sundeep Grandhe and Dr. Urvi Shah have been named to the Association for Value-Based Cancer Care’s ‘2026 Class of 40 Under 40 in Cancer,’ recognizing their significant contributions to oncology and patient care.
NEW YORK — On May 13, the Association for Value-Based Cancer Care (AVBCC) announced the selection of Dr. Sundeep Grandhe and Dr. Urvi Shah, both oncologists of Indian heritage, for its esteemed ‘2026 Class of 40 Under 40 in Cancer’ awards. This recognition underscores the important roles that young professionals are playing in enhancing cancer care and advancing research in the oncology field.
The AVBCC’s announcement indicated that the honorees were chosen from a highly competitive applicant pool of approximately 2,800 nominees, indicating the high caliber of individuals recognized. The award acknowledges excellence across various domains, including research, clinical care, and advocacy, and aims to spotlight emerging leaders in the oncology sector.
Profiles of the Honorees
Dr. Sundeep Grandhe is a quadruple board-certified physician-executive renowned for his extensive expertise in both palliative medicine and bioethics. He completed dual fellowships affiliated with Harvard University—specifically in hospice and palliative care at Beth Israel Deaconess Medical Center and in bioethics at the Harvard Center for Bioethics. Dr. Grandhe, originally from India, received his medical degree from Sri Ramachandra Medical College and Research Institute in Chennai before moving to the United States for advanced training.
In his practice, Dr. Grandhe emphasizes the importance of culturally responsive and compassionate care, particularly focusing on medically underserved communities. His work addresses the needs of patients dealing with severe illnesses and complex end-of-life decisions, aiming to improve their quality of care during challenging times. His approach is particularly relevant in today’s healthcare landscape, where disparities in access to quality medical care persist.
Dr. Urvi Shah serves as an assistant attending physician with the Myeloma Service at Memorial Sloan Kettering Cancer Center in New York. She previously completed a fellowship at Montefiore Health System, further enhancing her expertise in hematology-oncology. Dr. Shah is a board-certified hematologist-oncologist specializing in the diagnosis and treatment of plasma cell disorders, which encompass conditions such as multiple myeloma and other related diseases.
Recognition and Upcoming Ceremony
In announcing this year’s honorees, the AVBCC issued a statement congratulating all recipients and underscoring their commitment to excellence in the field of cancer care. ‘Congratulations to all of this year’s honorees. We look forward to honoring your achievements and the impact you continue to make,’ the association noted. This sentiment reflects the organization’s broader mission to foster innovation and improvement in cancer treatment and patient care.
The formal recognition of Dr. Grandhe and Dr. Shah is set to take place on May 30 at the Palmer House in Chicago, where they will be celebrated alongside other emerging leaders in oncology. This event aims to highlight the ongoing efforts to improve patient outcomes through innovative practices and dedicated advocacy in the field of cancer treatment.
Significance of the Awards
The ’40 Under 40 in Cancer’ awards aim to illuminate the contributions of rising stars in oncology, particularly those who demonstrate exceptional commitment to enhancing cancer care and the patient experience. The recognition of professionals like Dr. Grandhe and Dr. Shah reflects a broader trend toward increasing diversity and representation within the medical community, especially in specialties that are addressing complex health challenges.
As the landscape of cancer treatment continues to evolve, the contributions of these honorees are expected to shape the future of oncology significantly. Their dedication to research, clinical practice, and advocacy aligns closely with the AVBCC’s mission to promote value-based healthcare and address the needs of patients from diverse backgrounds.
This award also highlights the critical role that young professionals play in the ongoing evolution of cancer care, particularly as they bring new perspectives and innovative solutions to long-standing challenges in the field. By recognizing these individuals, the AVBCC aims to inspire a new generation of healthcare leaders who are equipped to navigate the complexities of modern medicine.
The recognition of Dr. Grandhe and Dr. Shah not only celebrates their individual achievements but also serves as a catalyst for further discussions on the importance of cultural competence in healthcare, the need for continued research funding, and the overall imperative to improve healthcare access for all patients, particularly those from underserved communities.
In conclusion, the ’40 Under 40 in Cancer’ awards serve as a vital reminder of the ongoing contributions of young professionals in oncology, illustrating the potential for future advancements in cancer care driven by fresh ideas and passionate advocates. The upcoming ceremony in Chicago will undoubtedly serve as an inspiring occasion, showcasing the remarkable accomplishments of these honorees and their commitment to improving the lives of patients battling cancer.
No Comment! Be the first one.